Skip to main content
Kolinpharma logo

Kolinpharma — Investor Relations & Filings

Ticker · KIP ISIN · IT0005322950 LEI · 815600FC8F1A3BED2743 XMIL Manufacturing
Open in API
Filings indexed 222 across all filing types
Latest filing 2020-10-30 Board/Management Inform…
Country IT Italy
Listing XMIL KIP

About Kolinpharma

https://www.kolinpharma.com/index-en

Kolinpharma is a nutraceutical company established in 2013, specializing in the research and development of innovative products designed to improve well-being and quality of life. The company's core activities are centered on scientific research and product innovation, creating high-quality nutraceuticals. It operates an in-house R&D department and collaborates with leading universities for in-vitro and clinical studies. As a certified B Corporation, Kolinpharma adheres to high standards of social and environmental performance. The company distributes its proprietary branded products through a qualified network of medical-scientific representatives.

Recent filings

Filing Released Lang Actions
KOLINPHARMA NOMINA MIT SIM NUOVO OPERATORE SPECIALISTA
Board/Management Information Classification · 1% confidence The document is an official regulatory announcement (indicated by 'Informazione Regolamentata' and 'REGEM' type) from KOLINPHARMA S.p.A. The subject ('Oggetto') is the 'NOMINA MIT SIM NUOVO OPERATORE SPECIALISTA' (Appointment of MIT SIM as New Specialist Operator). This concerns a change in the company's financial/listing advisors, which is a material event affecting investor relations and market operations. Since the document is short (under 5,000 characters) and announces an action rather than providing a full periodic report (like 10-K or IR), it fits best under general regulatory announcements. While it relates to capital markets, it is not a standard financial report, dividend notice, or management change. Given the options, 'Regulatory Filings' (RNS) is the most appropriate general category for material, non-standard announcements that don't fit specific financial reporting codes, especially when the core content is an administrative/advisory change.
2020-10-30 Italian
KOLINPHARMA differimento decorrenza della cessazione del contratto di specialist
Regulatory Filings Classification · 1% confidence The document is a formal communication from KOLINPHARMA S.p.A. dated October 28, 2020, identified as 'Informazione Regolamentata' (Regulated Information) under AIM-Italia rules. The subject ('Oggetto') is the postponement of the termination date of the Specialist contract ('differimento decorrenza della cessazione del contratto di specialist'). This type of announcement, which concerns administrative or procedural changes related to market operations or regulatory roles (like the Specialist/Nominated Adviser), and is issued as a formal press release/regulatory notice, fits best under the general category for regulatory announcements that aren't specific financial reports, director dealings, or capital changes. Since it is a formal notice regarding an administrative/regulatory relationship update, and not a core financial report (10-K, IR, ER) or a specific event like a dividend or AGM, the most appropriate classification is Regulatory Filings (RNS), which serves as a broad category for official market communications that don't fit elsewhere. The document length is moderate (5347 chars), but its content is purely an announcement of an administrative change, not the full report itself.
2020-10-28 Italian
KOLINPHARMA AVVIA LA VENDITA ON LINE CON KIP®KIT
Regulatory Filings Classification · 1% confidence The document is titled 'Informazione Regolamentata' (Regulated Information) and is dated October 26, 2020. The subject is 'LINE CON KIP®KIT' and the content announces the start of online sales for a new product bundle (KIP®KIT). This is a specific corporate announcement regarding a business development/product launch, not a periodic financial report (like 10-K or IR), a management change (MANG), or a dividend notice (DIV). Since it is a specific, non-financial regulatory announcement detailing a business action, it fits best under the general 'Regulatory Filings' category (RNS) as a miscellaneous regulatory disclosure, or potentially a general business update if a more specific category existed. Given the provided definitions, RNS serves as the best fit for a specific, non-standard regulatory announcement that isn't covered by the other specific codes (like DIRS, DLST, or CAP). The document length is moderate (5053 chars), but the content is purely an announcement of an action, not the full report itself.
2020-10-26 Italian
KOLINPHARMA OTTIENE IL 5^ BREVETTO IN USA PER IL PRODOTTO MILESAX
Regulatory Filings Classification · 1% confidence The document is a formal communication titled 'Informazione Regolamentata' (Regulated Information) from KOLINPHARMA S.p.A. The subject ('Oggetto') is 'KOLINPHARMA OTTIENE IL 5^ MILESAX BREVETTO IN USA PER IL PRODOTTO' (KOLINPHARMA OBTAINS THE 5TH MILESAX PATENT IN THE USA FOR THE PRODUCT). The content details the granting of a new US patent (Patent no. 10583120) for their product Milesax®. This type of announcement, concerning intellectual property rights, strategic developments, or specific corporate actions that are not standard periodic financial reports (like 10-K or IR), typically falls under general regulatory announcements or specific categories if available. Since it is not a financial report, earnings release, management discussion, or director dealing, and it is a specific corporate update, it is best classified as a general Regulatory Filing (RNS) as it is a mandatory disclosure of a material event, or potentially a Legal Proceedings Report (LTR) if patents were considered legal matters, but RNS is the broader, safer fallback for non-standard material news. Given the context of obtaining a patent, which is a significant corporate event but not explicitly covered by other codes like CAP, LTR, or DIV, RNS (Regulatory Filings / miscellaneous announcements) is the most appropriate general classification for this type of material, non-financial disclosure.
2020-09-30 Italian
KOLINPHARMA SPA-IL CDA APPROVA LA RELAZIONE FINANZIARIA SEMESTRALE AL 30 GIUGNO 2020.SEGNALI POSITIVI DI RIPRESA DEL MERCATO NEL 3^ TRIMESTRE
Earnings Release Classification · 1% confidence The document is a press release from KOLINPHARMA S.p.A. announcing the approval of its semi-annual financial report (Relazione Finanziaria Semestrale) for the period ending June 30, 2020. It provides a summary of key financial results (Revenue, EBITDA, Net Result, etc.) and business highlights. While it summarizes financial data, it is a corporate communication/press release rather than the full, formal interim financial report itself. According to the 'Menu vs Meal' rule, this is an announcement of the report's approval and publication, fitting the definition of an Earnings Release (ER) as it provides the initial announcement of periodical financial results and key highlights. H1 2020
2020-09-29 Italian
KOLINPHARMA PARTECIPA ALLA VII EDIZIONE DELL'AIM INVESTOR DAY
Report Publication Announcement Classification · 1% confidence The document is a formal announcement dated September 28, 2020, stating that KOLINPHARMA S.p.A. will participate in the 'VII edizione dell'AIM Investor Day' on October 1, 2020. The purpose of this event is for the company to present its 'equity story, results, and strategies' to institutional investors and the press. The text explicitly mentions that the institutional presentation will be made available on the Investor Relations section of the company website. Since the document itself is an announcement about the company's participation in an investor event where a presentation will be given, and it directs readers to where the presentation materials will be published, it fits the description of an announcement regarding the publication or presentation of company information, rather than being the full Investor Presentation (IP) or a comprehensive financial report. Therefore, the most appropriate classification is Report Publication Announcement (RPA), as it announces the upcoming presentation/event where materials will be shared.
2020-09-28 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.